Literature DB >> 17222403

Runx3 regulates dendritic epidermal T cell development.

Eilon Woolf1, Ori Brenner, Dalia Goldenberg, Ditsa Levanon, Yoram Groner.   

Abstract

The Runx3 transcription factor regulates development of T cells during thymopoiesis and TrkC sensory neurons during dorsal root ganglia neurogenesis. It also mediates transforming growth factor-beta signaling in dendritic cells and is essential for development of skin Langerhans cells. Here, we report that Runx3 is involved in the development of skin dendritic epidermal T cells (DETCs); an important component of tissue immunoregulation. In developing DETCs, Runx3 regulates expression of the alphaEbeta7 integrin CD103, known to affect migration and epithelial retention of DETCs. It also regulates expression of IL-2 receptor beta (IL-2Rbeta) that mediates cell proliferation in response to IL-2 or IL-15. In the absence of Runx3, the reduction in CD103 and IL-2Rbeta expression on Runx3(-/-) DETC precursors resulted in impaired cell proliferation and maturation, leading to complete lack of skin DETCs in Runx3(-/-) mice. The data demonstrate the requirement of Runx3 for DETCs development and underscore the importance of CD103 and IL-2Rbeta in this process. Of note, while Runx3(-/-) mice lack both DETCs and Langerhans cells, the two most important components of skin immune surveillance, the mice did not develop skin lesions under pathogen-free (SPF) conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17222403     DOI: 10.1016/j.ydbio.2006.12.005

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  23 in total

Review 1.  Interplay of transcription factors in T-cell differentiation and function: the role of Runx.

Authors:  Won Fen Wong; Kazuyoshi Kohu; Tomoki Chiba; Takehito Sato; Masanobu Satake
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

Review 2.  The RUNX complex: reaching beyond haematopoiesis into immunity.

Authors:  Dominic Chih-Cheng Voon; Yit Teng Hor; Yoshiaki Ito
Journal:  Immunology       Date:  2015-10-25       Impact factor: 7.397

Review 3.  Molecular mechanisms that control mouse and human TCR-alphabeta and TCR-gammadelta T cell development.

Authors:  Tom Taghon; Ellen V Rothenberg
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

Review 4.  Transcriptional programming of tissue-resident memory CD8+ T cells.

Authors:  J Justin Milner; Ananda W Goldrath
Journal:  Curr Opin Immunol       Date:  2018-04-02       Impact factor: 7.486

Review 5.  Epidermal T cells and wound healing.

Authors:  Wendy L Havran; Julie M Jameson
Journal:  J Immunol       Date:  2010-05-15       Impact factor: 5.422

6.  Placental DNA methylation alterations associated with maternal tobacco smoking at the RUNX3 gene are also associated with gestational age.

Authors:  Jennifer Z J Maccani; Devin C Koestler; Eugene Andrés Houseman; Carmen J Marsit; Karl T Kelsey
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

7.  A novel HMM-based method for detecting enriched transcription factor binding sites reveals RUNX3 as a potential target in pancreatic cancer biology.

Authors:  Liron Levkovitz; Nir Yosef; Marvin C Gershengorn; Eytan Ruppin; Roded Sharan; Yoram Oron
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

Review 8.  TGFbeta and retinoic acid intersect in immune-regulation.

Authors:  Daniel Mucida; Hilde Cheroutre
Journal:  Cell Adh Migr       Date:  2007-07-20       Impact factor: 3.405

Review 9.  Epidermal resident γδ T cell development and function in skin.

Authors:  Yingping Xu; Peter Dimitrion; Steven Cvetkovski; Li Zhou; Qing-Sheng Mi
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

10.  ZBTB7B (ThPOK) Is Required for Pathogenesis of Cerebral Malaria and Protection against Pulmonary Tuberculosis.

Authors:  David Langlais; Philippe Gros; James M Kennedy; Anna Georges; Angelia V Bassenden; Silvia M Vidal; Albert M Berghuis; Ichiro Taniuchi; Jacek Majewski; Mark Lathrop; Marcel A Behr
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.